Showing results (281-290 of 367) with videos related to

Sort By:
Pageof 37
British Journal of Clinical Pharmacology|May 1, 1997
Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerabilityD E Newby, D G Sciberras, C M Mendel, et al.
European Journal of Pharmacology|September 2, 2000
Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryl trinitrate-tolerant rat femoral arteriesM R Miller, I L Megson, M J Roseberry, et al.
European Journal of Pharmacology|November 25, 2000
Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryltrinitrate-tolerant rat femoral arteriesM R Miller, M J Roseberry, F A Mazzei, et al.
Translational Psychiatry|July 27, 2012
Absence of Ca2+-stimulated adenylyl cyclases leads to reduced synaptic plasticity and impaired experience-dependent fear memoryL Wieczorek, D Majumdar, T A Wills, et al.
Scottish Medical Journal|April 1, 1985
A comparison of atenolol and long-acting trimazosin in mild to moderate essential hypertensionD J Webb, M J Hutcheson, M P Robertson, et al.
Biochemical and Biophysical Research Communications|June 15, 1992
The potassium channel opener BRL 38227 inhibits binding of [125I]-labelled endothelin-1 to rat cardiac membranesC J Waugh, M E Dockrell, W G Haynes, et al.
The Journal of Physiology|February 7, 2001
Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in manI B Wilkinson, H MacCallum, P C Hupperetz, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Modulators of calcium and potassium channels: their effects on endothelin-1 binding to cardiac membranesW G Haynes, C J Waugh, M E Dockrell, et al.
Thrombosis and Haemostasis|November 19, 1997
An in vivo model for the assessment of acute fibrinolytic capacity of the endotheliumD E Newby, R A Wright, C A Ludlam, et al.
British Journal of Cancer|December 3, 2009
Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapyN L Henry, A Nguyen, F Azzouz, et al.
Pageof 37